Clinical trial
Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as…
NCT00246636 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00246636 |
|---|---|
| Title | Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Omacor Therapy in Hypertriglyceridemic Subjects Treated With Antara, Followed by an 8-week Extension |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertriglyceridemia |
| Intervention type | Drug |
| Interventions | Antara (fenofibrate) + Lovaza, Antara (fenofibrate) |
| Enrollment | 167 |
| Start date | Oct 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Oct 31, 2005 |
| Last update posted | Dec 14, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: